Multiple Sclerosis That Is Progressive From the Time of Onset: Clinical Characteristics and Progression of Disability

作者: P. B. Andersson , E. Waubant , L. Gee , D. E. Goodkin

DOI: 10.1001/ARCHNEUR.56.9.1138

关键词:

摘要: Objective: To use the new consensus definitions of primary progressive multiple sclerosis (PPMS) and relapsing (PRMS) to report demographic, clinical, natural history characteristics (MS) that is from time onset. Design: Retrospective study by database/chart review telephone interview. Setting: Multiple clinic at a university teaching hospital. Patients: Eighty-three patients (prevalence, 6.9%) with PPMS 12 1.0%) PRMS were studied. Results: Fifty-nine percent (n = 49) 67% 8) women. Mean ± SD ages onset 41.2 10.5 38.0 7.3 years, respectively; mean disease duration was 14.2 8.8 12.2 6.5 respectively. The initial symptoms involved leg weakness in 94% 78) 100% 12). For cohort, syndrome consistent isolated myelopathy found 36% 30) arm without did not occur. SEM progression score 6.0 on Expanded Disability Status Scale 10.2 1.0 years for 10.9 2.6 PRMS. Conclusions: clinical disability these MS subtypes indistinguishable, exception 1 or 2 relapses occurred 8 months 9 after symptoms. We see little reason consider separate entities; however, whether they can be better distinguished radiological, histopathological, immunological markers activity remains unknown. Arch Neurol. 1999;56:1138-1142

参考文章(19)
M. Filippi, V. Martinelli, T. Locatelli, S. Medaglini, A. Poggi, A. Visciani, G. Scotti, N. Canal, G. Comi, Acute- and insidious-onset myelopathy of undetermined aetiology: contribution of paraclinical tests to the diagnosis of multiple sclerosis Journal of Neurology. ,vol. 237, pp. 171- 176 ,(1990) , 10.1007/BF00314590
G Giovannoni, J W Thorpe, D Kidd, B E Kendall, I F Moseley, A J Thompson, G Keir, D H Miller, M Feldmann, E J Thompson, Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease. Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 60, pp. 20- 26 ,(1996) , 10.1136/JNNP.60.1.20
B. G. WEINSHENKER, B. BASS, G. P. A. RICE, J. NOSEWORTHY, W. CARRIERE, J. BASKERVILLE, G. C. EBERS, The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. ,vol. 112, pp. 133- 146 ,(1989) , 10.1093/BRAIN/112.1.133
T. Revesz, D. Kidd, A. J. Thompson, R. O. Barnard, W. I. McDonald, A comparison of the pathology of primary and secondary progressive multiple sclerosis Brain. ,vol. 117, pp. 759- 765 ,(1994) , 10.1093/BRAIN/117.4.759
Alan J. Thompson, A. G. Kermode, D. Wicks, D. G. MacManus, B. E. Kendall, D. P. E. Kingsley, W. I. McDonald, Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Annals of Neurology. ,vol. 29, pp. 53- 62 ,(1991) , 10.1002/ANA.410290111
J. M. Minderhoud, J. H. Hoeven, A. J. A. Prange, COURSE AND PROGNOSIS OF CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS - RESULTS OF AN EPIDEMIOLOGICAL-STUDY Acta Neurologica Scandinavica. ,vol. 78, pp. 10- 15 ,(1988) , 10.1111/J.1600-0404.1988.TB03611.X
Giancarlo Comi, Massimo Filippi, Vittorio Martinelli, Adraina Campi, Mariaemma Rodegher, Margherita Alberoni, Graziella Sirabian, Nicola Canal, Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis Journal of the Neurological Sciences. ,vol. 132, pp. 222- 227 ,(1995) , 10.1016/0022-510X(95)00168-2
F. D. Lublin, S. C. Reingold, , Defining the clinical course of multiple sclerosis Results of an international survey Neurology. ,vol. 46, pp. 907- 911 ,(1996) , 10.1212/WNL.46.4.907
Donald E Goodkin, MS clinical trial design for the future. Multiple Sclerosis Journal. ,vol. 1, pp. 393- 399 ,(1996) , 10.1177/135245859600100623